Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
Colorcon
Express Scripts
Boehringer Ingelheim

Last Updated: November 11, 2019

DrugPatentWatch Database Preview

Litigation Details for UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. (D.N.J. 2012)

See Plans and Pricing

« Back to Dashboard

UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. (D.N.J. 2012)

Docket   Start Trial Date Filed 2012-03-14
Court District Court, D. New Jersey Date Terminated 2014-08-29
Cause 35:145 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Magistrate Judge Lois H. Goodm
Parties SANDOZ, INC.; UNITED THERAPEUTICS CORPORATION; XYZ CORP.
Patents 5,153,222; 6,765,117; 7,999,007
Attorneys CHRISTINA LYNN SAVERIANO; DAVID C. KISTLER; ERIC I. ABRAHAM; RACHEL JANE GALLAGHER; STEPHEN M. ORLOFSKY
Link to Docket External link to docket
Small Molecule Drugs cited in UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. (D.N.J. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-03-14 1 seq., involving United States Patent Nos. 5,153,222 (“the ’222 patent”) (attached as Exhibit A hereto… or more claims of the ’222 patent, the ’117 patent, and the ’007 patent, which have all been listed … A. has infringed the’222 patent, the ’117 patent, and/or the ’007 patent, B. will actively…infringement of the ’222 patent, the ’117 patent, and/or the ’007 patent, and …expiration dates of the ’222 patent, the ’117 patent, and/or the ’007 patent, inclusive of any extension External link to document
2013-07-18 101 Supplement Its Invalidity Contentions for US Patent No 6,765,117. (mmh) (Entered: 07/18/2013) 18 July … 29 August 2014 3:12-cv-01617-PGS-LHG Patent None District Court, D. New Jersey External link to document
2013-11-18 123 Brief Judgment of Invalidity As to the Claims of U.S. Patent No. 7,999,007 by SANDOZ, INC.. (Attachments: # 1 Text … 29 August 2014 3:12-cv-01617-PGS-LHG Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Harvard Business School
Mallinckrodt
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.